Transauricular Neurostimulation for Abdominal Pain Due to DGBI
Key facts
- Where
- Columbus, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 12 and 18 years old?
Source: NCT07798180, who can take part
Where in United States
- Nationwide Children's HospitalColumbus, United StatesContact: Peter Lu, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Nationwide Children's Hospital
- Trial code
- NCT07798180
- Record updated
- 1 September 2026
- Original description
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents aged 12 to 18 years with abdominal pain related to disorders of gut-brain interaction. Up to 30 participants will be enrolled, with a goal of 20 completing the study. Participants will use the device for at least one hour daily for 4 weeks and complete questionnaires through week 8. The study will assess adherence, retention, safety, and preliminary changes in abdominal pain, bowel symptoms, quality of life, and anxiety.Read full original descriptionShow less
Transauricular Neurostimulation for Irritable Bowel Syndrome
This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents aged 12 to 18 years with abdominal pain related to disorders of gut-brain interaction. Up to 30 participants will be enrolled, with a goal of 20 completing the study. Participants will use the device for at least one hour daily for 4 weeks and complete questionnaires through week 8. The study will assess adherence, retention, safety, and preliminary changes in abdominal pain, bowel symptoms, quality of life, and anxiety.
Inclusion: Age 12-18 years; Clinical diagnosis of an abdominal pain-related disorder of gut-brain interaction (DGBI) meeting Rome IV criteria; Average abdominal pain intensity ≥3 on a 0-10 scale and pain on at least 2 days per week; Proper fit of the Sparrow earpiece on the left ear, as determined by study personnel.
Exclusion: Change in medications used to treat abdominal pain or gastrointestinal symptoms within 2 weeks before enrollment. Participants must be on stable doses for at least 2 weeks before enrollment; Medical or psychiatric condition that contraindicates transauricular neurostimulation or creates a safety risk; Abnormal ear anatomy preventing earpiece placement; Developmental delay; Implanted electronic device or hearing aid; Participation in another interventional trial; Pregnancy; Unable to communicate in English; Prisoner.